BSE Live
Dec 30, 16:01Prev. Close
2686.75
Open Price
2687.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 15:56Prev. Close
2690.20
Open Price
2702.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2726.90 (43)
| Balance Sheet of Ajanta Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 11.80 | 11.80 | |
| Total Share Capital | 11.80 | 11.80 | |
| Reserves and Surplus | 89.51 | 160.73 | |
| Total Reserves and Surplus | 89.51 | 160.73 | |
| Total Shareholders Funds | 101.31 | 172.53 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 39.34 | 39.73 | |
| Deferred Tax Liabilities [Net] | 0.00 | 6.81 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 39.34 | 46.54 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 40.73 | 19.81 | |
| Trade Payables | 22.90 | 20.57 | |
| Other Current Liabilities | 0.01 | 0.01 | |
| Short Term Provisions | 0.06 | 0.06 | |
| Total Current Liabilities | 63.71 | 40.46 | |
| Total Capital And Liabilities | 204.35 | 259.53 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 46.85 | 46.23 | |
| Intangible Assets | 0.00 | 40.11 | |
| Capital Work-In-Progress | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 46.85 | 86.34 | |
| Non-Current Investments | 14.95 | 45.75 | |
| Deferred Tax Assets [Net] | 13.54 | 2.75 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | |
| Total Non-Current Assets | 75.34 | 134.84 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 60.43 | 46.28 | |
| Trade Receivables | 59.63 | 56.96 | |
| Cash And Cash Equivalents | 1.34 | 1.16 | |
| Short Term Loans And Advances | 7.62 | 20.29 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 129.02 | 124.69 | |
| Total Assets | 204.35 | 259.53 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 10.47 | 3.76 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 8.63 | 2.27 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.02 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 5.86 | 4.18 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 130.47 | 64.60 | |
| Other Earnings | 4.42 | 2.76 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 1.23 | 1.23 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | -- | |
| Non-Current Investments Unquoted Book Value | 14.95 | 45.75 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
30.12.2025
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct